Scarica l'app Stockscreener
89.69
4.61%
3.95
Dopo l'orario di chiusura:
90.00
0.31
+0.35%
Billiontoone Inc Borsa (BLLN) Ultime notizie
BillionToOne expands liquid biopsy platform with two add-on tests By Investing.com - Investing.com South Africa
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - Finviz
BillionToOne, Inc. Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - marketscreener.com
BillionToOne expands liquid biopsy platform with two add-on tests - Investing.com
BillionToOne Expands Northstar Platform with Launch of Two New A - GuruFocus
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PR Newswire
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - BioSpace
BillionToOne Expands Leadership in HDFN and FNAIT Testing - Intellectia AI
BillionToOne Leads 3 Value Stock Picks That May Offer Investment Opportunities - Yahoo Finance
BillionToOne Inc (BLLN) Shares Up 2.91% on Feb 2 - GuruFocus
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
BillionToOne, Inc. Completes Successful IPO Raising $314 Million - MSN
BillionToOne Inc (BLLN) Shares Up 3.56% on Jan 27 - GuruFocus
Billiontoone (NASDAQ:BLLN) Trading 6.3% HigherStill a Buy? - MarketBeat
Assessing BillionToOne (BLLN) Valuation After Recent Share Price Pullback - Yahoo Finance
Assessing BillionToOne (BLLN) Valuation As Mixed Recent Returns Meet Conflicting Growth Expectations - simplywall.st
BillionToOne Inc (BLLN) Shares Up 7.3% on Jan 22 - GuruFocus
Billiontoone (NASDAQ:BLLN) Sets New 1-Year LowWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM) - The Globe and Mail
BillionToOne Inc (BLLN) Trading Down 4.99% on Jan 20 - GuruFocus
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne Inc (BLLN) Stock Price Down 3.55% on Jan 16 - GuruFocus
BillionToOne integrates prenatal and oncology tests with Epic EHR By Investing.com - Investing.com Nigeria
BillionToOne Integrates Prenatal and Oncology Tests into Epic Aura Diagnostics Suite - TipRanks
BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite - marketscreener.com
BillionToOne Announces Collaboration with Epic to Expand Prenata - GuruFocus
BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - marketscreener.com
BillionToOne integrates prenatal and oncology tests with Epic EHR - Investing.com
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - PR Newswire
Billiontoone (NASDAQ:BLLN) Stock Price Down 6%Here's What Happened - MarketBeat
What's Going On With BillionToOne Shares Tuesday? - Benzinga
BillionToOne reaffirms 2025 guidance, projects 40-45% revenue growth in 2026 - Investing.com Nigeria
BillionToOne Stock (+15%): Strong '26 Guidance Spurs Re-Rate - Trefis
BillionToOne: Reaffirmed Growth Targets and Upside to 2026 Support Reiterated Buy Rating - TipRanks
BillionToOne reaffirms FY25 guidance - MSN
(BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M - marketscreener.com
BillionToOne Issues Strong 2026 Growth and Profit Outlook - TipRanks
Billiontoone provides guidance for 2026 - marketscreener.com
BillionToOne Provides Guidance for 2026 - The Manila Times
Billiontoone Provides Guidance For 2026 - TradingView — Track All Markets
BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN
BillionToOne initiated with a Buy at Stifel - MSN
BillionToOne, Inc.: Revenue and Earnings Analysts Forecasts Revisions | BPJH | US0901681058 - marketscreener.com
January 2026's Top Growth Companies With Insider Confidence - Yahoo Finance
After tax other income/expense of BillionToOne, Inc. Class A – BX:BLLN - TradingView — Track All Markets
Billiontoone (NASDAQ:BLLN) Now Covered by Guggenheim - MarketBeat
BillionToOne initiated with a buy at Guggenheim - MSN
BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East - marketscreener.com
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):